Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 5213K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lee, S. Articles by Iruela-Arispe, M. L. Search for Related Content PubMed PubMed Citation Articles by Lee, S. Articles by Iruela-Arispe, M. L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Cancer Related Collections Related Article Social Bookmarking                      What's this?

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

¹ Department of Molecular, Cell, and Developmental Biology
² Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095
³ Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095

Correspondence to M. Luisa Iruela-Arispe: arispe{at}mbi.ucla.edu

Vascular endothelial growth factor (VEGF) is a critical mediator of blood vessel formation during development and in pathological conditions. In this study, we demonstrate that VEGF bioavailability is regulated extracellularly by matrix metalloproteinases (MMPs) through intramolecular processing. Specifically, we show that a subset of MMPs can cleave matrix-bound isoforms of VEGF, releasing soluble fragments. We have mapped the region of MMP processing, have generated recombinant forms that mimic MMP-cleaved and MMP-resistant VEGF, and have explored their biological impact in tumors. Although all forms induced similar VEGF receptor 2 phosphorylation levels, the angiogenic outcomes were distinct. MMP-cleaved VEGF promoted the capillary dilation of existent vessels but mediated a marginal neovascular response within the tumor. In contrast, MMP-resistant VEGF supported extensive growth of thin vessels with multiple and frequent branch points. Our findings support the view that matrix-bound VEGF and nontethered VEGF provide different signaling outcomes. These findings reveal a novel aspect in the regulation of extracellular VEGF that holds significance for vascular patterning.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Two VEGFs for big or branchy vessels

Nicole LeBrasseur
J. Cell Biol. 2005 169: 549. [Full Text] [PDF]

This article has been cited by other articles:

• Stratman, A. N., Saunders, W. B., Sacharidou, A., Koh, W., Fisher, K. E., Zawieja, D. C., Davis, M. J., Davis, G. E. (2009). Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood 114: 237-247 [Abstract] [Full Text]  
• Lukkarinen, H., Hogmalm, A., Lappalainen, U., Bry, K. (2009). Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia. Am. J. Respir. Cell Mol. Bio. 41: 59-68 [Abstract] [Full Text]  
• MacLauchlan, S., Skokos, E. A., Agah, A., Zeng, J., Tian, W., Davidson, J. M., Bornstein, P., Kyriakides, T. R. (2009). Enhanced Angiogenesis and Reduced Contraction in Thrombospondin-2-null Wounds Is Associated With Increased Levels of Matrix Metalloproteinases-2 and -9, and Soluble VEGF. J. Histochem. Cytochem. 57: 301-313 [Abstract] [Full Text]  
• Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., Carmeliet, P. (2009). Role and Therapeutic Potential of VEGF in the Nervous System. Physiol. Rev. 89: 607-648 [Abstract] [Full Text]  
• Ito, T.-K., Ishii, G., Saito, S., Yano, K., Hoshino, A., Suzuki, T., Ochiai, A. (2009). Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 113: 2363-2369 [Abstract] [Full Text]  
• Rullman, E., Norrbom, J., Stromberg, A., Wagsater, D., Rundqvist, H., Haas, T., Gustafsson, T. (2009). Endurance exercise activates matrix metalloproteinases in human skeletal muscle. J. Appl. Physiol. 106: 804-812 [Abstract] [Full Text]  
• Kurtagic, E., Jedrychowski, M. P., Nugent, M. A. (2009). Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L534-L546 [Abstract] [Full Text]  
• Hughes, D., Fu, A. A., Puggioni, A., Glockner, J. F., Anwer, B., McGuire, A. M., Mukhopadhyay, D., Misra, S. (2009). Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway--a pilot study. Nephrol Dial Transplant 24: 85-96 [Abstract] [Full Text]  
• McCawley, L. J., Wright, J., LaFleur, B. J., Crawford, H. C., Matrisian, L. M. (2008). Keratinocyte Expression of MMP3 Enhances Differentiation and Prevents Tumor Establishment. Am. J. Pathol. 173: 1528-1539 [Abstract] [Full Text]  
• Kawamura, H., Li, X., Goishi, K., van Meeteren, L. A., Jakobsson, L., Cebe-Suarez, S., Shimizu, A., Edholm, D., Ballmer-Hofer, K., Kjellen, L., Klagsbrun, M., Claesson-Welsh, L. (2008). Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112: 3638-3649 [Abstract] [Full Text]  
• Krady, M. M., Zeng, J., Yu, J., MacLauchlan, S., Skokos, E. A., Tian, W., Bornstein, P., Sessa, W. C., Kyriakides, T. R. (2008). Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis. Am. J. Pathol. 173: 879-891 [Abstract] [Full Text]  
• Butler, G. S., Dean, R. A., Tam, E. M., Overall, C. M. (2008). Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding. Mol. Cell. Biol. 28: 4896-4914 [Abstract] [Full Text]  
• Cebe-Suarez, S., Grunewald, F. S., Jaussi, R., Li, X., Claesson-Welsh, L., Spillmann, D., Mercer, A. A., Prota, A. E., Ballmer-Hofer, K. (2008). Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J. 22: 3078-3086 [Abstract] [Full Text]  
• Janssen, A., Hoellenriegel, J., Fogarasi, M., Schrewe, H., Seeliger, M., Tamm, E., Ohlmann, A., May, C. A., Weber, B. H. F., Stohr, H. (2008). Abnormal Vessel Formation in the Choroid of Mice Lacking Tissue Inhibitor of Metalloprotease-3. IOVS 49: 2812-2822 [Abstract] [Full Text]  
• Criswell, M. H., Hu, W.-Z., Steffens, T. J., Li, R., Margaron, P. (2008). Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model. Arch Ophthalmol 126: 946-952 [Abstract] [Full Text]  
• Misra, S., Fu, A. A., Puggioni, A., Karimi, K. M., Mandrekar, J. N., Glockner, J. F., Juncos, L. A., Anwer, B., McGuire, A. M., Mukhopadhyay, D. (2008). Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am. J. Physiol. Heart Circ. Physiol. 294: H2219-H2230 [Abstract] [Full Text]  
• van Hinsbergh, V. W.M., Koolwijk, P. (2008). Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78: 203-212 [Abstract] [Full Text]  
• Silvestre, J.-S., Mallat, Z., Tedgui, A., Levy, B. I. (2008). Post-ischaemic neovascularization and inflammation. Cardiovasc Res 78: 242-249 [Abstract] [Full Text]  
• Tozer, G. M., Akerman, S., Cross, N. A., Barber, P. R., Bjorndahl, M. A., Greco, O., Harris, S., Hill, S. A., Honess, D. J., Ireson, C. R., Pettyjohn, K. L., Prise, V. E., Reyes-Aldasoro, C. C., Ruhrberg, C., Shima, D. T., Kanthou, C. (2008). Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors. Cancer Res. 68: 2301-2311 [Abstract] [Full Text]  
• Belotti, D., Calcagno, C., Garofalo, A., Caronia, D., Riccardi, E., Giavazzi, R., Taraboletti, G. (2008). Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion. Mol Cancer Res 6: 525-534 [Abstract] [Full Text]  
• Holderfield, M. T., Hughes, C. C.W. (2008). Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-{beta} in Vascular Morphogenesis. Circ. Res. 102: 637-652 [Abstract] [Full Text]  
• Gutierrez, J., Konecny, G. E., Hong, K., Burges, A., Henry, T. D., Lambiase, P. D., Lee Wong, W., Meng, Y. G. (2008). A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors. Clin. Chem. 54: 597-601 [Abstract] [Full Text]  
• Herve, M.-A., Buteau-Lozano, H., Vassy, R., Bieche, I., Velasco, G., Pla, M., Perret, G., Mourah, S., Perrot-Applanat, M. (2008). Overexpression of Vascular Endothelial Growth Factor 189 in Breast Cancer Cells Leads to Delayed Tumor Uptake with Dilated Intratumoral Vessels. Am. J. Pathol. 172: 167-178 [Abstract] [Full Text]  
• Vempati, P., Karagiannis, E. D., Popel, A. S. (2007). A Biochemical Model of Matrix Metalloproteinase 9 Activation and Inhibition. J. Biol. Chem. 282: 37585-37596 [Abstract] [Full Text]  
• Mineur, P., Colige, A. C., Deroanne, Christophe. F., Dubail, J., Kesteloot, F., Habraken, Y., Noel, A., Voo, S., Waltenberger, J., Lapiere, C. M., Nusgens, B. V., Lambert, C. A. (2007). Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. JCB 179: 1261-1273 [Abstract] [Full Text]  
• Dean, R. A., Butler, G. S., Hamma-Kourbali, Y., Delbe, J., Brigstock, D. R., Courty, J., Overall, C. M. (2007). Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis . Mol. Cell. Biol. 27: 8454-8465 [Abstract] [Full Text]  
• Ji, J. W., Mac Gabhann, F., Popel, A. S. (2007). Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am. J. Physiol. Heart Circ. Physiol. 293: H3740-H3749 [Abstract] [Full Text]  
• Dai, J., Rabie, A.B.M. (2007). VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification. JDR 86: 937-950 [Abstract] [Full Text]  
• Spinale, F. G. (2007). Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function. Physiol. Rev. 87: 1285-1342 [Abstract] [Full Text]  
• Krilleke, D., DeErkenez, A., Schubert, W., Giri, I., Robinson, G. S., Ng, Y.-S., Shima, D. T. (2007). Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain. J. Biol. Chem. 282: 28045-28056 [Abstract] [Full Text]  
• Peters, S., Julien, S., Heiduschka, P., Grisanti, S., Ziemssen, F., Adler, M., Schraermeyer, U., Bartz-Schmidt, K.-U., the Tuebingen Bevacizumab Study Group, (2007). Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br. J. Ophthalmol. 91: 827-831 [Abstract] [Full Text]  
• Simons, M. (2007). Silky, Sticky Chimeras-Designer VEGFs Display Their Wares. Circ. Res. 100: 1402-1404 [Full Text]  
• Keskitalo, S., Tammela, T., Lyytikka, J., Karpanen, T., Jeltsch, M., Markkanen, J., Yla-Herttuala, S., Alitalo, K. (2007). Enhanced Capillary Formation Stimulated by a Chimeric Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor-C Silk Domain Fusion Protein. Circ. Res. 100: 1460-1467 [Abstract] [Full Text]  
• Tammela, T., He, Y., Lyytikka, J., Jeltsch, M., Markkanen, J., Pajusola, K., Yla-Herttuala, S., Alitalo, K. (2007). Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins. Circ. Res. 100: 1468-1475 [Abstract] [Full Text]  
• Cretu, A., Roth, J. M., Caunt, M., Akalu, A., Policarpio, D., Formenti, S., Gagne, P., Liebes, L., Brooks, P. C. (2007). Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis. Clin. Cancer Res. 13: 3068-3078 [Abstract] [Full Text]  
• Kong, D., Li, Y., Wang, Z., Banerjee, S., Sarkar, F. H. (2007). Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-{kappa}B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer. Cancer Res. 67: 3310-3319 [Abstract] [Full Text]  
• Yang, L. V., Radu, C. G., Roy, M., Lee, S., McLaughlin, J., Teitell, M. A., Iruela-Arispe, M. L., Witte, O. N. (2007). Vascular Abnormalities in Mice Deficient for the G Protein-Coupled Receptor GPR4 That Functions as a pH Sensor. Mol. Cell. Biol. 27: 1334-1347 [Abstract] [Full Text]  
• Milkiewicz, M., Hudlicka, O., Shiner, R., Egginton, S., Brown, M. D. (2006). Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J. Physiol. 577: 671-678 [Abstract] [Full Text]  
• Banu, N., Teichman, J., Dunlap-Brown, M., Villegas, G., Tufro, A. (2006). Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20: 2150-2152 [Abstract] [Full Text]  
• Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., Evan, G. I. (2006). The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes Dev. 20: 2527-2538 [Abstract] [Full Text]  
• Salvador, G., Sanmarti, R., Gil-Torregrosa, B., Garcia-Peiro, A., Rodriguez-Cros, J. R., Canete, J. D. (2006). Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 966-971 [Abstract] [Full Text]  
• Torres-Collado, A. X., Kisiel, W., Iruela-Arispe, M. L., Rodriguez-Manzaneque, J. C. (2006). ADAMTS1 Interacts with, Cleaves, and Modifies the Extracellular Location of the Matrix Inhibitor Tissue Factor Pathway Inhibitor-2. J. Biol. Chem. 281: 17827-17837 [Abstract] [Full Text]  
• Punyadeera, C., Thijssen, V.L., Tchaikovski, S., Kamps, R., Delvoux, B., Dunselman, G.A.J., de Goeij, A.F.P.M., Griffioen, A.W., Groothuis, P.G. (2006). Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod 12: 367-375 [Abstract] [Full Text]  
• Duda, D. G. (2006). Antiangiogenesis and drug delivery to tumors: bench to bedside and back.. Cancer Res. 66: 3967-3970 [Abstract] [Full Text]  
• Camp, E. R., Yang, A., Liu, W., Fan, F., Somcio, R., Hicklin, D. J., Ellis, L. M. (2006). Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in an In vivo Model of Pancreatic Cancer. Clin. Cancer Res. 12: 2628-2633 [Abstract] [Full Text]  
• van Hinsbergh, V. W.M., Engelse, M. A., Quax, P. H.A. (2006). Pericellular Proteases in Angiogenesis and Vasculogenesis. Arterioscler. Thromb. Vasc. Bio. 26: 716-728 [Abstract] [Full Text]  
• Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., Shinomura, Y. (2006). Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis. Exp. Biol. Med. 231: 20-27 [Abstract] [Full Text]  
• Davis, G. E., Senger, D. R. (2005). Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization. Circ. Res. 97: 1093-1107 [Abstract] [Full Text]  
• Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., Iruela-Arispe, M. L. (2005). Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. JEM 201: i14-14 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents